
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Historical Deciles for [NKTR] Nektar Therapeutics
Data updated 2025-Apr-11 (Friday)Compare current performance/technical metrics to history for Nektar Therapeutics. Range of values presented below in deciles puts current values into historical context (Up to 5-years)
Provided As-is for informational/educational purposes only and should not be construed as investment advice . Past performance may not be not indicative of future results. Always consult your Investment Adviser before any decision
Share
Use widget to view Historical Metric Deciles for other Stocks/ETFs/Indices
Summary 2025-Apr-11 Friday
Day Change | +23.76% Top | Day Volatility | 23.13% Top |
Streak | ↑ 1 day Mid | % Streak | +23.76% Top |
RSI | 42 Mid | CCI | -56.2 Mid |
MACD | -0.02 Mid | ATR | 0.08 Low |
ADX | 22.7 Mid | SSO | 14.7 Low |
Change | Volatility | % off SMA | |
---|---|---|---|
5-day | +11.92% Top | 51.16% Top | +18.33% Top |
10-day | -16.33% Low | 67.44% Top | +7.63% Top |
20-day | -31.12% Low | 123.26% Top | -12.74% Low |
50-day | -27.38% Low | 151.16% Top | -21.16% Low |
100-day | -47.21% Low | 190.70% Mid | -30.37% Low |
200-day | -42.27% Mid | 253.49% Mid | -43.16% Low |
Choose Metric type
Select Performance timeframe above to analyze
On 2025-Apr-11, Nektar Therapeutics had:daily change of +23.76% intraday volatility of 23.1% 1 ↑(up) day streak yielding +23.76% See how this compares to historical ranges below. Upto last 5 years are bucketed into deciles (click on chart line for details) with 2025-Apr-11 value annotated for comparison
Related to Nektar Therapeutics
Information for Nektar Therapeutics
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets Currently Viewing
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-Apr-15 on Google
SEC Reports : Quarterly reports around 2025-Apr-15 on SEC Edgar
Compare Nektar Therapeutics with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Nektar Therapeutics
Industry : Pharmaceuticals industry performance which includes Nektar Therapeutics